Abraham Ceesay
2021 - Cerevel Therapeutics Holdings
In 2021, Abraham Ceesay earned a total compensation of $5.3M as President at Cerevel Therapeutics Holdings.
Compensation breakdown
| Bonus | $250,000 |
|---|---|
| Non-Equity Incentive Plan | $172,264 |
| Option Awards | $4,499,994 |
| Salary | $335,249 |
| Other | $19,124 |
| Total | $5,276,631 |
Ceesay received $4.5M in option awards, accounting for 85% of the total pay in 2021.
Ceesay also received $250K in bonus, $172.3K in non-equity incentive plan, $335.2K in salary and $19.1K in other compensation.
Rankings
In 2021, Abraham Ceesay's compensation ranked 2,460th out of 12,415 executives tracked by ExecPay. In other words, Ceesay earned more than 80.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,460 out of 12,415 | 80th |
Division Manufacturing | 976 out of 5,505 | 82nd |
Major group Chemicals And Allied Products | 375 out of 2,375 | 84th |
Industry group Drugs | 327 out of 2,096 | 84th |
Industry Pharmaceutical Preparations | 216 out of 1,546 | 86th |
Source: SEC filing on April 28, 2022.
Ceesay's colleagues
We found five more compensation records of executives who worked with Abraham Ceesay at Cerevel Therapeutics Holdings in 2021.
2021
N Coles
Cerevel Therapeutics Holdings
Chief Executive Officer
2021
Kathy Yi
Cerevel Therapeutics Holdings
Chief Financial Officer
2021
Raymond Sanchez
Cerevel Therapeutics Holdings
Chief Medical Officer
2021
Scott Akamine
Cerevel Therapeutics Holdings
Chief Legal Officer
2021
Mark Bodenrader
Cerevel Therapeutics Holdings